Scinai Immunotherapeutics Ltd. has acquired Recipharm Israel Ltd., operator of Recipharm’s manufacturing site in Yavne, and signed a long‑term commercial collaboration with Recipharm aimed at expanding its contract development and manufacturing (CDMO) operations. The deal gives Scinai full ownership of the Yavne cGMP facility, which provides early chemistry development and small‑scale API manufacturing for clinical‑stage drug programs. Financial terms weren’t disclosed. Scinai said the transa...